Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1976-05-24
1977-12-13
Rosen, Sam
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
A61K 3748
Patent
active
040629414
ABSTRACT:
The present invention encompasses a method for treating fungal infections in animals comprising administering to animals in need of antifungal treatment an effective amount of fungal cell lytic enzymes extracted from Coprinus, Lycoperdon, or Bolbitius in conjunction with conventional antimycotic agents such as amphotericin B or Nystatin. The fungal cell lytic enzymes are extracted from Coprinus, Lycoperdon, and Bolbitius by conventional enzyme isolation techniques. These fungal cell lytic enzymes retain their activity in vivo, are relatively non toxic and destroy fungi by degrading fungal cell walls and weakening the fungal cell walls so that conventional antimycotic agents are far more effective. The method of the present invention is particularly useful in treating infections by opportunistic fungi such as Aspergillus fumigatus and Candida albicans.
REFERENCES:
kawai - Chem. Abst. vol. 73, (1970), p. 73196K.
G. D. Searle & Co. Ltd.
McDonnell John J.
Rosen Sam
LandOfFree
Method for treating fungal infections using cell lytic enzymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating fungal infections using cell lytic enzymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating fungal infections using cell lytic enzymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-489393